Company Quick10K Filing
Fuse Medical
10-Q 2020-03-31 Filed 2020-05-22
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-12
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-31 Filed 2019-03-21
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-06
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-20
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-11
10-K 2015-12-31 Filed 2016-03-25
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-07-18
10-Q 2014-02-28 Filed 2014-03-26
10-Q 2013-11-30 Filed 2014-01-13
10-K 2013-08-31 Filed 2013-11-15
10-Q 2013-02-28 Filed 2013-05-13
10-Q 2012-11-30 Filed 2013-01-22
10-K 2012-08-31 Filed 2012-12-13
10-Q 2012-05-31 Filed 2012-07-13
10-Q 2012-02-29 Filed 2012-04-06
10-Q 2011-11-30 Filed 2011-12-28
10-K 2011-08-31 Filed 2011-12-08
10-Q 2011-05-31 Filed 2011-06-30
10-Q 2011-02-28 Filed 2011-04-08
10-Q 2010-11-30 Filed 2011-01-14
10-K 2010-08-31 Filed 2010-11-30
10-Q 2010-05-31 Filed 2010-07-09
10-Q 2010-02-28 Filed 2010-03-31
10-Q 2009-11-30 Filed 2010-01-14
8-K 2020-05-06 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-12-18 Enter Agreement, Exhibits
8-K 2019-10-23 Officers
8-K 2019-06-26 Shareholder Vote, Exhibits
8-K 2019-06-01 Accountant, Exhibits
8-K 2019-05-09 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-05-08 Other Events, Exhibits
8-K 2019-04-26 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-03-21 Other Events, Exhibits
8-K 2019-03-20 Amend Bylaw, Exhibits
8-K 2019-03-14 Other Events, Exhibits
8-K 2019-02-09 Shareholder Vote, Exhibits
8-K 2018-12-13 Enter Agreement, Officers, Exhibits
8-K 2018-11-19 Enter Agreement, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2018-07-30 Enter Agreement, M&A, Sale of Shares, Regulation FD, Exhibits
8-K 2018-06-28 Officers, Exhibits
8-K 2018-02-15 Regulation FD, Exhibits
8-K 2018-01-18 Officers
8-K 2018-01-05 Off-BS Arrangement, Accountant, Other Events, Exhibits
8-K 2017-12-29 M&A, Regulation FD, Exhibits

Fuse Medical Financials

FZMD Metrics, Comps, Filings

Quarterly | Annual

Business

We were initially incorporated in 1968 as GolfRounds, Inc., a Florida corporation. During July 1999, GolfRounds, Inc. was re-domesticated to Delaware through a merger into its wholly-owned subsidiary GolfRounds.com, Inc. Effective May 28, 2014, GolfRounds.com, Inc. amended its certificate of incorporation to change its name to Fuse Medical, Inc. ("Fuse" or our "Company") and merged with and into Fuse Medical, LLC, with Fuse Medical, LLC surviving as a wholly-owned subsidiary of Fuse. The transaction was accounted for as a reverse merger. Fuse was the legal acquirer, and Fuse Medical, LLC was deemed the accounting acquirer. During 2015, certificates of termination were filed for Fuse Medical, LLC and its two subsidiaries.

On December 19, 2016 (the "Change-in-Control Date"), we entered into a Stock Purchase Agreement (the "Stock Purchase Agreement") by and between NC 143 Family Holdings, LP, a Texas limited partnership ("NC 143") which is controlled by Mark W. Brooks ("Mr. Brooks"), our Chairman of our Board of Directors ("Board") and President; and Reeg Medical Industries, Inc., a Texas corporation, ("RMI", and together with NC 143, the "Investors"), which is owned and controlled by Christopher C. Reeg, our Chief Executive Officer and Secretary ("Mr. Reeg"). The closing of the Stock Purchase Agreement resulted in a change-in-control of our Company whereby the Investors beneficially acquired approximately 61.4% of our issued and outstanding shares of common stock, par value $0.01 per share ("Common Stock"), immediately after the Change-in-Control Date.

On December 31, 2017 we completed the acquisition of CPM Medical Consultants, LLC ("CPM") in which we purchased all outstanding membership units of CPM pursuant to the securities purchase agreement ("CPM Acquisition Agreement" and such transaction the "CPM Acquisition"). In the CPM Acquisition, Fuse was the legal acquirer, and for accounting purposes, CPM was deemed to have acquired Fuse. As a result, this 2018 Annual Report reflects CPM as the reporting entity for 2017 and 2016 and is consolidated with Fuse effective on the Change-in-Control Date.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Cortland Bancorp (CLDB) 95,237 7.1 1% 700,621 626,468 0 0 5,378 10,511 74,729
ChoiceOne Financial Services (COFS) 94,691 0% 8.1 1% 663,589 578,963 3,629 0 5,973 9,668 78,117
Aerkomm (AKOM) 94,280 1% -11.7 -17% 51,277 3,924 1,600 13 -8,941 -7,810 91,529
Invuity (IVTY) 92,683 67% -2.9 -75% 48,729 46,397 40,834 27,211 -36,461 -31,788 93,415
First National (FXNC) 92,475 0% 5.0 1% 777,193 701,877 5,726 0 6,840 12,425 62,102
Nobility Homes (NOBH) 92,404 28% 9.0 11% 55,980 7,733 35,568 10,061 5,899 7,955 71,257
NCL (NCLC) 90,687 0% 4.3 6% 15,931,783 9,700,324 6,385,388 0 973,844 1,432,690 6,107,285
Cannapharmarx (CPMD) 90,342 -12.2 -50% 22,468 9,856 0 0 -11,137 -7,963 97,149
Humanigen (HGEN) 90,224 -12.4 -1,392% 594 13,260 0 0 -8,268 -7,265 89,996
Mattersight (MATR) 89,019 72% -20.5 -39% 28,863 32,587 50,383 36,274 -11,234 -4,549 93,093
Farmers & Merchants Bancshares (FMFG) 89,000 7.8 1% 434,506 385,511 0 0 4,637 8,851 69,405
Fuse Medical (FZMD) 88,479 42% -23.1 -26% 18,157 20,920 15,563 6,576 -4,717 -3,781 87,448
Tropic International (TRPO) 86,318 -98.1 -69% 1,279 3,897 0 0 -878 -878 86,112
Anvia Holdings (ANVV) 86,395 51% -26.9 -22% 15,045 13,273 10,410 5,300 -3,382 -3,189 85,681
Liberated Syndication (LSYN) 85,599 86% 13.7 7% 42,855 13,372 18,203 15,621 3,195 5,639 77,064
Community Bancorp (CMTV) 84,437 5.3 1% 729,232 661,911 0 0 8,596 15,952 84,437
Elite Pharmaceuticals (ELTP) 83,284 34% -15.1 -27% 23,533 12,688 12,032 4,083 -6,324 -5,332 80,626
Bowl America (BWLA) 82,317 0% 17.2 10% 29,755 6,452 24,102 0 2,894 4,728 81,193
Liquidmetal Technologies (LQMT) 82,292 23% -7.6 -18% 41,972 1,489 920 216 -7,584 -6,736 51,068
Trevi Therapeutics (TRVI) 81,861 -0.9 -30% 66,022 5,313 0 0 -19,513 -19,527 18,346

Balance Sheet ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash48226000012765987752368581757885121626674464454728057986905958448528421,031
Accounts Receivable110130110196192316173298843522581232162856,5704,7093,5563,5265,2263,2203,9114,759
Inventory307278273131151976881472532252219810,62710,25311,22511,04411,07611,00010,7668,190
PP&E485162636363555956444444141372727516369696363
Assets58291664211229251,2281,38798554652152436943525921013776762971979719,24717,21017,35320,09622,17320,20020,65218,157
Accounts Payable197235272277192312200296241206114837589622,5881,5342,6402,3552,7131,5182,3952,526
Long-Term Debt17801129011,5291,5120117117100100100100100
Liabilities2923335080102124501161321,2611,9342,00434736047137843037841838431729539241727,22925,78826,15025,10420,70619,00019,33920,920
Stockholders' Equity286-18-44-76-101-123-39-87-106-33-546-1,01919916154-95-119-207-247451334327379-7,982-8,578-8,797-5,0071,4671,2001,313-2,763
Income Statement ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue16226320730926348744348419312110814833542825,4966,0045,7186,7844,7715,0765,716
Cost of Revenue591057324993178165227812143594811517014,2493,1243,7703,0471,9752,2244,788
Gross Profit10315913460169309278257112100658710022025811,2472,8811,9483,7372,7952,852928
R&D
SG&A2,2072,2931,9332,3641,9762,264
Tax00-208-38891-115-40927
Net Income-29-22-24-26-32-24-22-31-48-19-126-454-473-352-217-118-48114-124-88-113-260-116-731792-735-1,615277-511-142-4,064
Cash Flow ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-5-26-16-6-0-10-4-37-62-170-448-776-304-296-9458-437735-159-222-0271,8007351,24188134-311
Cash Investing-46-10-10-1-0-6000000-12-75
Cash Financing0000437638631,3691,349-15028753-17000100-742-1,261-81-144500